Clik here to view.
越南卫生部和昆泰携手推进卓越临床试验研究
新加坡 (美国商业资讯)–昆泰今日宣布，越南卫生部科学、技术和培训管理局(ASTT)已与昆泰签署了一项协议，该协议旨在促进这一拥有9000万人口快速发展国家的临床研究。 ASTT局长阮功汗(Nguyen Cong Khan, M.D., Ph.D.)教授指出，这一合作标志着越南卫生部致力于支持相关疾病更佳新疗法的开发进入了一个新阶段，这些疾病一直折磨着越南和东南亚的广大民众。...
View ArticleClik here to view.
Australian Motion Analysis Pioneer, dorsaVi Ltd, Launches $18M Initial Public...
MELBOURNE, Australia dorsaVi Ltd, an Australian-based company specialising in the development and commercialisation of wireless and wearable sensor movement monitoring products, has issued a...
View ArticleClik here to view.
Quintiles Named Best CRO at SCRIP Awards, Quintiles Infosario Safety System...
RESEARCH TRIANGLE PARK, N.C. Quintiles has received Scrip Awards’ Best Contract Research Organization honors for the second year running, and Best Technological Development in Clinical Trials for...
View ArticleClik here to view.
ResearchDx, the Leading Contract Diagnostics Organization, Expands Operations...
MUMBAI ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Indian biopharmaceutical and diagnostics markets. As part of this...
View ArticleClik here to view.
ADDING MULTIMEDIA CHMP Recommends Otsuka’s Deltyba™ (delamanid) for EU...
Smart Multimedia Gallery Micrographed Mycobacterium tuberculosis (Photo: Business Wire) View and Share Photo Download Small TOKYO Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the...
View ArticleClik here to view.
ADDING MULTIMEDIA 大塚製薬: 多剤耐性結核の治療薬として開発中の「デラマニド」欧州医薬品委員会が販売承認を推奨
Smart Multimedia Gallery 染色された結核菌（電子顕微鏡写真）（写真：ビジネスワイヤ） View and Share Photo Download Small 東京 （ビジネスワイヤ） —...
View ArticleClik here to view.
ベトナム保健省とクインタイルズ、臨床試験の卓越性向上を目指して連携
シンガポール （ビジネスワイヤ） — クインタイルズは本日、人口9千万人を抱える新興国のベトナムで臨床研究を強化するための契約をベトナム保健省科学技術訓練局（ASTT）と結んだと発表しました。 ASTT局長のNguyen Cong...
View ArticleClik here to view.
Arrowhead Submits Application to Begin Phase 2a Trial of ARC-520 for the...
PASADENA, Calif. Arrowhead Research Corporation (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it recently filed an application for approval...
View ArticleClik here to view.
昆泰荣获SCRIP大奖最佳CRO称号；昆泰Infosario安全系统荣获最佳技术开发奖
北卡罗来纳州三角研究园 (美国商业资讯)–昆泰(Quintiles)连续第二年荣获Script大奖的最佳合同研究组织(CRO)称号，而且昆泰Infosario安全系统还首次荣获最佳临床试验技术开发奖。Script大奖旨在表彰生物制药业的卓越成就，获奖者由15位生命科学专家组成的独立评委会评选产生。第9届年度颁奖典礼在英国伦敦举行，有来自全球各地的400多位业界领导者参加了颁奖典礼。...
View ArticleClik here to view.
SillaJen Announces Agreement to Acquire Jennerex, Inc.
BUSAN, South Korea & SAN FRANCISCO SillaJen, Inc., a privately-held biotherapeutics and contract research company focused on the development of targeted biological products for cancer, announced...
View ArticleClik here to view.
オックスフォード・イムノテック・グローバル、新規株式公開価格を発表
英オックスフォード、米マサチューセッツ州マールボロ ビジネスワイヤ） — オックスフォード・イムノテック・グローバル（NASDAQ:...
View ArticleClik here to view.
クインタイルズがスクリップ賞の最優秀CROに選出され、クインタイルズ・インフォサリオ・セーフティー・システムで最優秀技術開発賞を獲得
米ノースカロライナ州リサーチ・トライアングル・パーク （ビジネスワイヤ） — クインタイルズは、スクリップ賞の「最優秀CRO（医薬品開発業務受託機関）賞」を2年連続で、またクインタイルズ・インフォサリオ・セーフティー・システム (Quintiles Infosario Safety...
View ArticleClik here to view.
Everest Group Recognizes HCL as a Leader and Star Performer in the Life...
SUNNYVALE, Calif. & NOIDA, India HCL Technologies, a leading global IT services company today announced that it has been recognized as a “Leader” and “Star Performer” category in life sciences...
View ArticleClik here to view.
Innate Immunotherapeutics Launches IPO to Raise up to A$12 Million
SYDNEY Medical biotechnology company Innate Immunotherapeutics has today announced its plans to raise up to A$12 million through an IPO of up to 60 million shares at A$0.20 per share. Firm...
View ArticleClik here to view.
Gland Pharma and KKR Announce Partnership
MUMBAI, India Gland Pharma Limited (“Company” or “Gland Pharma”), a leading Indian pure-play generic injectable pharmaceutical products company, today announced an agreement under which KKR, a...
View ArticleClik here to view.
Data from Final Cohort of Patients in Patrys Multiple Myeloma Clinical Trial
MELBOURNE, Australia Patrys Limited (ASX:PAB), a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma (MM) will be...
View ArticleClik here to view.
Promega ADCC Reporter Bioassay Named to The Scientist Top 10 Innovations for...
Smart Multimedia Gallery Representation of Promega ADCC Reporter Bioassay. Readout is luminescence signal from NFAT response element driving expression of firefly luciferase in the engineered Jurkat...
View ArticleClik here to view.
22nd Century Group收购破产制造厂的设备
纽约州Clarence (美国商业资讯)–22nd Century Group, Inc. (OTCBB:XXII)今天宣布，该公司已经收购了位于北卡罗来纳州莫克斯维尔的一家香烟制造厂的所有设备。截至目前，22nd Century Group的子公司Goodrich Tobacco Company的所有产品都通过合同制造商生产。 22nd Century Group与NASCO...
View ArticleClik here to view.
Teva and Takeda Announce Agreement for Glatiramer Acetate for Multiple...
JERUSALEM & OSAKA, Japan Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Takeda Pharmaceutical Company Limited (Takeda) today announced the signing earlier this year of an agreement in which...
View ArticleClik here to view.
Melior Licenses Novel Diabetes Drug to Bukwang Pharmaceutical Co.
EXTON, Pa. Melior Pharmaceuticals I, Inc. today announced a licensing agreement with Bukwang Pharmaceutical Co. Ltd., of South Korea to develop, manufacture and commercialize its lead compound...
View Article